LA JOLLA — The immune system’s emergency alarm never shuts off in an Alzheimer’s brain. Now scientists know why.
Researchers at Scripps Research have identified a single molecular change that locks the brain’s inflammatory response into a damaging, permanent state. The culprit is a protein called STING. Normally it functions as a silent sentinel, waking up only when a virus or bacteria invades. In Alzheimer’s disease, STING gets chemically altered and stays stuck in the “on” position.
This matters because most Alzheimer’s drug trials have failed. They targeted amyloid plaques, the sticky protein clumps that build up between neurons. Those drugs did not stop cognitive decline. The field has been searching for another path.
Neuroinflammation is that other path. The Scripps team, led by neurologist Stuart Lipton, found that the protein clumps known to drive Alzheimer’s — amyloid-beta and alpha-synuclein — directly trigger the STING alteration. Once triggered, STING pours out inflammatory signals that destroy the connections between neurons. Those connections, called synapses, are what allow the brain to think and remember. Their loss correlates directly with cognitive decline.
The change happens at a single building block on the STING protein, an amino acid called cysteine 148. A chemical group gets added there. That modification turns a useful immune alarm into a source of constant, destructive inflammation.
What makes this discovery different from previous attempts to treat neuroinflammation is precision. Broad anti-inflammatory drugs suppress the entire immune response. That leaves the brain vulnerable to real infections. Targeting the specific modification at cysteine 148 quiets only the harmful overactivation. Normal immune defenses stay intact.
Lipton’s team tested this in mice. They blocked the modification. The result was a significant reduction in neuroinflammation. The synaptic connections that had been under attack were protected.
The finding also explains why aging and environmental factors worsen Alzheimer’s. Aging itself raises levels of nitric oxide in the brain. So does air pollution. So does wildfire smoke. Nitric oxide drives the chemical change that hyperactivates STING. This creates a self-perpetuating cycle: more nitric oxide, more STING activation, more inflammation, more synaptic damage.
This is not a cure. The work is still early. The researchers are now developing small molecules designed to block the harmful modification on STING. Those molecules would need to pass through years of clinical trials before reaching patients.
But the mechanism is now clear. The molecular switch exists. The team knows exactly where it is — on cysteine 148. They know what flips it — amyloid-beta, alpha-synuclein, nitric oxide. And they know how to flip it back off, at least in mice.
The implication is straightforward. Alzheimer’s has been treated as a disease of protein buildup. That approach has not worked. This discovery reframes the disease as one of immune dysregulation. The inflammation is not a side effect. It is the engine. And now researchers have a target that lets them shut down the engine without disabling the rest of the immune system.
Lipton’s team published their findings June 5. The paper identifies STING as the molecular switch locking Alzheimer’s inflammation on. The next step is turning that switch off in people.
